Johnson & Johnson Sues Rival Boehringer Ingelheim Corporation Over Arbitration Dispute

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Johnson & Johnson (JNJ:US) sued a unit of rival drugmaker Boehringer Ingelheim Gmbh over whether a dispute about an agreement must be heard by an arbitrator. Officials of New Brunswick, New Jersey-based J&J, the world’s biggest seller of health-care products, want a Delaware judge to force Boehringer’s U.S. subsidiary to submit a contract dispute to arbitration, according to court filings. The actual complaint in the case was filed under seal today.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC